Clinical comparison of three liver scanning agents

Area of Science:

• Nuclear Medicine
• Radiopharmacology
• Diagnostic Imaging

Background:

• Radiocolloids are crucial for diagnostic imaging, particularly for the liver and spleen.
• Different formulations of technetium-99m (99mTc) colloids exist, each with potential advantages and disadvantages.
• Accurate quantitative assessment of organ uptake is essential for reliable diagnostic interpretation.

Purpose of the Study:

• To quantitatively compare the biological distributions of three 99mTc-labeled colloids: sulphur colloid, tin colloid, and phytate colloid.
• To evaluate the suitability of each radiopharmaceutical for diagnostic imaging, focusing on liver and splenic uptake.
• To determine the most effective and practical radiopharmaceutical among the tested options.

Main Methods:

• A randomized trial was conducted to compare the biological distributions of 99mTc-sulphur colloid, 99mTc-tin colloid, and 99mTc phytate colloid.
• Quantitative analysis of radiopharmaceutical distribution was performed.
• Liver and splenic uptake were specifically assessed.

Main Results:

• All three radiopharmaceuticals (99mTc-sulphur colloid, 99mTc-tin colloid, 99mTc phytate colloid) produced satisfactory liver images.
• 99mTc phytate colloid demonstrated a significant underestimation of splenic uptake.
• 99mTc-tin colloid was easier to dispense than 99mTc-sulphur colloid.

Conclusions:

• 99mTc-tin colloid is the most suitable radiopharmaceutical for liver and spleen imaging among the tested agents.
• The ease of dispensing and accurate splenic uptake assessment make 99mTc-tin colloid preferable.
• Phytate colloid's underestimation of splenic uptake limits its clinical utility.